Evidence map›Paper›PMID 36615263›Full record

ArticleMolecules (Basel, Switzerland)2022

Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome.

Kansate Prasertsuk, Kasidit Prongfa, Piyapach Suttiwanich, Nathaphat Harnkit, Mattanun Sangkhawasi, Pongsakorn Promta, Pramote Chumnanpuen

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kansate PrasertsukPibulwitthayalai School, 777 Naraimaharach, Talaychoopsorn, Lopburi District, Lopburi 15000, Thailand.ORCID 0000-0003-2621-1140
Kasidit ProngfaPibulwitthayalai School, 777 Naraimaharach, Talaychoopsorn, Lopburi District, Lopburi 15000, Thailand.
Piyapach SuttiwanichPibulwitthayalai School, 777 Naraimaharach, Talaychoopsorn, Lopburi District, Lopburi 15000, Thailand.
Nathaphat HarnkitMedicinal Plant Research Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand.ORCID 0000-0002-6817-4889
Mattanun SangkhawasiProgram in Biotechnology, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-7211-0992
Pongsakorn PromtaPibulwitthayalai School, 777 Naraimaharach, Talaychoopsorn, Lopburi District, Lopburi 15000, Thailand.
Pramote ChumnanpuenOmics Center for Agriculture, Bioresources, Food and Health, Kasetsart University (OmiKU), Bangkok 10900, Thailand.ORCID 0000-0003-3072-1733

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To control the COVID-19 pandemic, antivirals that specifically target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently required. The 3-chymotrypsin-like protease (3CLpro) is a promising drug target since it functions as a catalytic dyad in hydrolyzing polyprotein during the viral life cycle. Bioactive peptides, especially food-derived peptides, have a variety of functional activities, including antiviral activity, and also have a potential therapeutic effect against COVID-19. In this study, the hemp seed trypsinized peptidome was subjected to computer-aided screening against the 3CLpro of SARS-CoV-2. Using predictive trypsinized products of the five major proteins in hemp seed (i.e., edestin 1, edestin 2, edestin 3, albumin, and vicilin), the putative hydrolyzed peptidome was established and used as the input dataset. To select the

Indexed as

CannabisCoronavirus Protease InhibitorsCOVID-19 Drug TreatmentPeptidesSARS-CoV-2Coronavirus 3C ProteasesHumansMolecular Docking SimulationMolecular Dynamics SimulationPandemics3C-like protease, SARS coronavirusCoronavirus 3C ProteasesCoronavirus Protease InhibitorsPeptidesantiviralhempmolecular dockingpeptideSARS-CoV-2 main protease

Identifiers

PMID36615263
PMCPMC9822321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.